A single-centre study investigating clinical outcomes of STEMI patients undergoing primary percutaneous coronary intervention implanted with the Combo stent.
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2016
At a glance
- Drugs Anti-CD34 monoclonal antibody/sirolimus (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2016 New trial record